Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
Study NCT ID:
NCT00269867
Status:
COMPLETED
Last Update Posted:
2014-11-04
First Post:
2005-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
Sponsor:
Centocor, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1997-03
Start Date Type:
None
Primary Completion Date:
2000-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2000-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-22
First Submit QC Date:
None
Study First Post Date:
2005-12-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-03
Last Update Post Date:
2014-11-04
Last Update Post Date Type:
ESTIMATED